Clinical presentations of soft-tissue infections and surgical site infections.
about
Chinese herbal medicines for treating skin and soft-tissue infectionsLinezolid versus vancomycin in treatment of complicated skin and soft tissue infections.Wound pathophysiology, infection and therapeutic options.Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections.CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycinNecrotizing fasciitis: pathogenesis and treatment.Therapies for necrotising fasciitis.Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary studyEmpirical antibiotics use in soft tissue infections.Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Synergistic Antimicrobial Effects of Silver/Transition-metal Combinatorial Treatments.Staphylococcus aureus-Associated Skin and Soft Tissue Infections: Anatomical Localization, Epidemiology, Therapy and Potential Prophylaxis.In vitro and clinical experience of Cutimed Sorbact: the evidence base.Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections.
P2860
Q24194810-AC167F65-B1C3-46A9-BC78-9289578D3741Q33836490-765325DF-0A65-40AB-9FA1-6816E2C31B8DQ35043411-168B2F81-1138-4686-B593-788D9A92FB6CQ35585106-45C58EB9-6917-44D9-888B-A2D8362023C5Q35941227-D79E0369-83F2-41E4-AC9D-DCCE826231C4Q35959558-0B610955-C873-4C52-A857-BABA31B2D35AQ36140694-2F4AC2CF-F14D-4FB6-A0E4-89EB04918FFAQ36377217-381498F1-E777-440E-B65E-08F1D17B1C69Q36663656-C5E9A36B-E598-4F3F-82F5-40F5B0452FCFQ37192126-E4E95043-0105-445E-986A-69D8370621E5Q37641770-AB5CD199-8501-4718-A88D-3C8750A136CCQ37785546-2CC0A3C7-C527-4496-8FE5-D6660E2614D7Q38728622-B8873C7A-C375-4A2F-9D65-3D233A9CDACEQ39287619-578703E2-5383-49D7-A187-69BFFEA8864EQ41158472-F2A7BED5-D7EB-4ADB-B7A2-B79D292C5B0BQ42686505-72B3B180-C79C-42D4-9567-076D728F778CQ44958309-CA4162F3-AADC-49BE-A02F-8F8E22F3C944
P2860
Clinical presentations of soft-tissue infections and surgical site infections.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical presentations of soft-tissue infections and surgical site infections.
@ast
Clinical presentations of soft-tissue infections and surgical site infections.
@en
Clinical presentations of soft-tissue infections and surgical site infections.
@nl
type
label
Clinical presentations of soft-tissue infections and surgical site infections.
@ast
Clinical presentations of soft-tissue infections and surgical site infections.
@en
Clinical presentations of soft-tissue infections and surgical site infections.
@nl
prefLabel
Clinical presentations of soft-tissue infections and surgical site infections.
@ast
Clinical presentations of soft-tissue infections and surgical site infections.
@en
Clinical presentations of soft-tissue infections and surgical site infections.
@nl
P2860
P356
P1476
Clinical presentations of soft-tissue infections and surgical site infections.
@en
P2093
P2860
P304
P356
10.1086/321862
P407
P478
33 Suppl 2
P577
2001-09-01T00:00:00Z